These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28236059)

  • 1. EWSR1 rearrangement is a frequent event in papillary thyroid carcinoma and in carcinoma of the thyroid with Ewing family tumor elements (CEFTE).
    Oliveira G; Polónia A; Cameselle-Teijeiro JM; Leitão D; Sapia S; Sobrinho-Simões M; Eloy C
    Virchows Arch; 2017 May; 470(5):517-525. PubMed ID: 28236059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EWSR1 rearrangement in papillary thyroid microcarcinoma is related to classic morphology and the presence of small-cell phenotype.
    Kovacevic B; Caramelo A; Skuletic V; Cerovic S; Eloy C
    Bosn J Basic Med Sci; 2022 Feb; 22(1):54-63. PubMed ID: 34374640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinomas of the Thyroid with Ewing Family Tumor Elements (CEFTEs): A Diagnostic Challenge Before Surgery.
    Taccogna S; Guglielmi R; Persichetti A; Morano C; Angelini F; Ienzi S; Scarpino S; Liverani A; Annovazzi A; Papini E
    Head Neck Pathol; 2021 Mar; 15(1):254-261. PubMed ID: 32077055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements.
    Colato C; Vicentini C; Cantara S; Pedron S; Brazzarola P; Marchetti I; Di Coscio G; Chilosi M; Brunelli M; Pacini F; Ferdeghini M
    Eur J Endocrinol; 2015 May; 172(5):571-82. PubMed ID: 25698220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
    Prasad ML; Vyas M; Horne MJ; Virk RK; Morotti R; Liu Z; Tallini G; Nikiforova MN; Christison-Lagay ER; Udelsman R; Dinauer CA; Nikiforov YE
    Cancer; 2016 Apr; 122(7):1097-107. PubMed ID: 26784937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications.
    Joung JY; Kim TH; Jeong DJ; Park SM; Cho YY; Jang HW; Jung YY; Oh YL; Yim HS; Kim YL; Chung JH; Ki CS; Kim SW
    Histopathology; 2016 Jul; 69(1):45-53. PubMed ID: 26568156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant BRAF(V600E) mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma.
    Guerra A; Zeppa P; Bifulco M; Vitale M
    Thyroid; 2014 Feb; 24(2):254-9. PubMed ID: 23806056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoma of the thyroid with ewing family tumor elements and favorable prognosis: report of a second case.
    Eloy C; Oliveira M; Vieira J; Teixeira MR; Cruz J; Sobrinho-Simões M
    Int J Surg Pathol; 2014 May; 22(3):260-5. PubMed ID: 23637256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas.
    Nozaki Y; Yamamoto H; Iwasaki T; Sato M; Jiromaru R; Hongo T; Yasumatsu R; Oda Y
    Hum Pathol; 2020 Dec; 106():82-92. PubMed ID: 32980422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ewing sarcoma of the small bowel: a study of seven cases, including one with the uncommonly reported EWSR1-FEV translocation.
    Milione M; Gasparini P; Sozzi G; Mazzaferro V; Ferrari A; Casali PG; Perrone F; Tamborini E; Pellegrinelli A; Gherardi G; Arrigoni G; Collini P; Testi A; De Paoli E; Aiello A; Pilotti S; Pelosi G
    Histopathology; 2014 Jun; 64(7):1014-26. PubMed ID: 24898918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene rearrangement analysis of papillary thyroid carcinoma].
    Wang YL; Wang JC; Li DS; Zhu YX; Wu Y; Ji QH
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 42(12):929-33. PubMed ID: 18335752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
    Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RET/PTC rearrangements arising from a small population of papillary thyroid carcinoma cells, possible candidate for passenger mutation.
    Nakazawa T; Murata S; Kondo T; Niu D; Mochizuki K; Kawasaki T; Yamane T; Nakamura N; Katoh R
    Virchows Arch; 2009 Jul; 455(1):35-41. PubMed ID: 19495791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.
    Mechler C; Bounacer A; Suarez H; Saint Frison M; Magois C; Aillet G; Gaulier A
    Br J Cancer; 2001 Dec; 85(12):1831-7. PubMed ID: 11747322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases.
    Woodford RL; Nikiforov YE; Hunt JL; Bellizzi AM; Zhang X; Mills SE; Stelow EB
    Am J Surg Pathol; 2010 Nov; 34(11):1582-90. PubMed ID: 20924280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma.
    Chou A; Fraser S; Toon CW; Clarkson A; Sioson L; Farzin M; Cussigh C; Aniss A; O'Neill C; Watson N; Clifton-Bligh RJ; Learoyd DL; Robinson BG; Selinger CI; Delbridge LW; Sidhu SB; O'Toole SA; Sywak M; Gill AJ
    Am J Surg Pathol; 2015 May; 39(5):652-9. PubMed ID: 25501013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and histopathologic characteristics of multifocal papillary thyroid carcinoma.
    Bansal M; Gandhi M; Ferris RL; Nikiforova MN; Yip L; Carty SE; Nikiforov YE
    Am J Surg Pathol; 2013 Oct; 37(10):1586-91. PubMed ID: 23797723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation and recommendation of the optimal methodologies to detect RET gene rearrangements in papillary thyroid carcinoma.
    Zhang T; Lu Y; Ye Q; Zhang M; Zheng L; Yin X; Gavine P; Sun Z; Ji Q; Zhu G; Su X
    Genes Chromosomes Cancer; 2015 Mar; 54(3):168-76. PubMed ID: 25407564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese.
    Liu RT; Chou FF; Wang CH; Lin CL; Chao FP; Chung JC; Huang CC; Wang PW; Cheng JT
    Thyroid; 2005 Apr; 15(4):326-35. PubMed ID: 15876154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RET/PTC Rearrangements Are Associated with Elevated Postoperative TSH Levels and Multifocal Lesions in Papillary Thyroid Cancer without Concomitant Thyroid Benign Disease.
    Su X; He C; Ma J; Tang T; Zhang X; Ye Z; Long Y; Shao Q; Shao J; Yang A
    PLoS One; 2016; 11(11):e0165596. PubMed ID: 27802347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.